AlphaYouSO
Schedule 13D filing
SR ONE CAPITAL MANAGEMENT, LLC disclosed a 9.3% stake in ADARx Pharmaceuticals, Inc. (ADRX)
SR ONE CAPITAL MANAGEMENT, LLC reported owning 9.3% of ADARx Pharmaceuticals, Inc. (ADRX) (9,936,661 shares) in a Schedule 13D filed Oct 5, 2026.
A 13D means the holder may push for changes at the company.
- Disclosed
- Oct 5, 2026
- Source
- Schedule 13D
More ADRX insider and Congress trades
From a public Schedule 13D, linked above. Not investment advice, and not a recommendation to buy or sell.